Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology.

Musette P, Janela B.

Front Med (Lausanne). 2017 Dec 4;4:179. doi: 10.3389/fmed.2017.00179. eCollection 2017. Review.

2.

HLA genotyping by next-generation sequencing of complementary DNA.

Segawa H, Kukita Y, Kato K.

BMC Genomics. 2017 Nov 28;18(1):914. doi: 10.1186/s12864-017-4300-7.

3.

HLAs: Key regulators of T-cell-mediated drug hypersensitivity.

Redwood AJ, Pavlos RK, White KD, Phillips EJ.

HLA. 2018 Jan;91(1):3-16. doi: 10.1111/tan.13183. Review.

4.

Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations.

Castells M.

Front Immunol. 2017 Nov 8;8:1472. doi: 10.3389/fimmu.2017.01472. eCollection 2017. Review.

5.

Reply to: Medication contaminants as a potential cause of anaphylaxis to vincristine: What about drug specific antigens?

Hill DA, Leahy AB, Sciasci J, O'Neill SP, Reilly A, Balamuth N, Seeholzer SH, Spergel JM, Brown-Whitehorn TF.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26868. Epub 2017 Oct 19. No abstract available.

PMID:
29049863
6.

Regional Experience of Abacavir: Valuable but Still has Unanswered Question.

Bang JH.

Infect Chemother. 2017 Sep;49(3):241-242. doi: 10.3947/ic.2017.49.3.241. No abstract available.

7.

Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients.

Ann H, Kim KH, Choi HY, Chang HH, Han SH, Kim KH, Lee JS, Kim YS, Park KH, Kim YK, Sohn JW, Yun NR, Lee CS, Choi YW, Lee YS, Kim SW.

Infect Chemother. 2017 Sep;49(3):205-212. doi: 10.3947/ic.2017.49.3.205.

8.

Severe Delayed Drug Reactions: Role of Genetics and Viral Infections.

Pavlos R, White KD, Wanjalla C, Mallal SA, Phillips EJ.

Immunol Allergy Clin North Am. 2017 Nov;37(4):785-815. doi: 10.1016/j.iac.2017.07.007. Review.

PMID:
28965641
9.

Efficacy of switching to dolutegravir plus rilpivirine, the small-tablet regimen, in patients with dysphagia: two case reports.

Suzuki T, Hara N, Osa M, Misawa K, Imai K, Fujikura Y, Maeda T, Sonehara W, Kawana A.

J Pharm Health Care Sci. 2017 Sep 19;3:23. doi: 10.1186/s40780-017-0093-8. eCollection 2017.

10.

Genetic Factors Influencing Drug-Induced Liver Injury: Do They Have a Role in Prevention and Diagnosis?

Clare KE, Miller MH, Dillon JF.

Curr Hepatol Rep. 2017;16(3):258-264. doi: 10.1007/s11901-017-0363-9. Epub 2017 Aug 7. Review.

11.

The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Trubiano JA, Stone CA, Grayson ML, Urbancic K, Slavin MA, Thursky KA, Phillips EJ.

J Allergy Clin Immunol Pract. 2017 Nov - Dec;5(6):1532-1542. doi: 10.1016/j.jaip.2017.06.017. Epub 2017 Aug 23. Review. Erratum in: J Allergy Clin Immunol Pract. 2018 Jan - Feb;6(1):323.

12.

Genomic testing as a tool to optimise drug therapy.

Somogyi AA, Phillips E.

Aust Prescr. 2017 Jun;40(3):101-104. doi: 10.18773/austprescr.2017.027. Epub 2017 Jun 1. Review. No abstract available.

14.

Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank.

Cortes A, Dendrou CA, Motyer A, Jostins L, Vukcevic D, Dilthey A, Donnelly P, Leslie S, Fugger L, McVean G.

Nat Genet. 2017 Sep;49(9):1311-1318. doi: 10.1038/ng.3926. Epub 2017 Jul 31.

PMID:
28759005
15.

Influence of Human Leukocyte Antigen (HLA) Alleles and Killer Cell Immunoglobulin-Like Receptors (KIR) Types on Heparin-Induced Thrombocytopenia (HIT).

Karnes JH, Shaffer CM, Cronin R, Bastarache L, Gaudieri S, James I, Pavlos R, Steiner HE, Mosley JD, Mallal S, Denny JC, Phillips EJ, Roden DM.

Pharmacotherapy. 2017 Sep;37(9):1164-1171. doi: 10.1002/phar.1983. Epub 2017 Sep 4.

PMID:
28688202
16.

The emerging science of precision medicine and pharmacogenomics for Parkinson's disease.

Payami H.

Mov Disord. 2017 Aug;32(8):1139-1146. doi: 10.1002/mds.27099. Epub 2017 Jul 7.

PMID:
28686320
17.

Structural Elements Recognized by Abacavir-Induced T Cells.

Yerly D, Pompeu YA, Schutte RJ, Eriksson KK, Strhyn A, Bracey AW, Buus S, Ostrov DA.

Int J Mol Sci. 2017 Jul 7;18(7). pii: E1464. doi: 10.3390/ijms18071464.

18.

Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches.

de Las Vecillas Sánchez L, Alenazy LA, Garcia-Neuer M, Castells MC.

Int J Mol Sci. 2017 Jun 20;18(6). pii: E1316. doi: 10.3390/ijms18061316. Review.

19.

Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.

Lu M, Lewis CM, Traylor M.

BMC Med Genomics. 2017 Jun 19;10(1):47. doi: 10.1186/s12920-017-0283-0.

20.

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?

Verbelen M, Weale ME, Lewis CM.

Pharmacogenomics J. 2017 Oct;17(5):395-402. doi: 10.1038/tpj.2017.21. Epub 2017 Jun 13. Review.

Supplemental Content

Support Center